Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-01-524488
Filing Date
2001-07-19
Accepted
2001-07-19 00:00:00
Documents
4
Group Members
FLEMING ROBERT INC / DAFLEMING US DISCOVERY , LLCFLEMING US DISCOVERY FUND III, L.P.FLEMING US DISCOVERY OFFSHORE FUND III, L.P.FLEMING US DISCOVERY PARTNERS, L.P.J.P. MORGAN CHASE & CO.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A a2054594zsc13da.txt SC 13D/A 53733
2 EXHIBIT 1 a2054594zex-1.txt EX-1 2477
3 EXHIBIT 2 a2054594zex-2.txt EX-2 84464
4 EXHIBIT 4 a2054594zex-4.txt EX-4 64388
  Complete submission text file 0000912057-01-524488.txt   207869
Mailing Address 320 PARK AVE 11TH AND 12TH FL NEW YORK NY 10022
Business Address 320 PARK AVENUE 11TH & 12TH FL NEW YORK NY 10022 2125083600
FLEMING ROBERT INC / DA (Filed by) CIK: 0000902812 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0331
SIC: 0000

Mailing Address CASTOR & KENSINGTON AVENUES PHILADELPHIA PA 19124-5694
Business Address 30831 HAYWARD AVE HAYWARD CA 94544 2152892220
IMPAX LABORATORIES INC (Subject) CIK: 0001003642 (see all company filings)

EIN.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48867 | Film No.: 1684793
SIC: 2834 Pharmaceutical Preparations